Utah Medical Products, Inc.
UTMD
$56.50
$1.021.83%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -19.68% | -20.87% | -16.60% | -9.74% | -9.39% |
| Total Depreciation and Amortization | -29.80% | -45.45% | -55.31% | -55.42% | -40.33% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 89.91% | 83.10% | 82.41% | -758.46% | -1,008.47% |
| Change in Net Operating Assets | -90.52% | -361.99% | -673.82% | 51.16% | 39.45% |
| Cash from Operations | -23.58% | -32.09% | -33.44% | -23.88% | -19.94% |
| Capital Expenditure | 18.38% | 36.57% | 64.01% | 47.02% | 43.49% |
| Sale of Property, Plant, and Equipment | -100.00% | -100.00% | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 100.00% | -- | -- | -- | -- |
| Cash from Investing | 13.73% | 32.83% | 67.45% | 50.77% | 46.54% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | 53.13% | 233.33% | 57.26% | 83.62% |
| Repurchase of Common Stock | -84.00% | -575.55% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 4.73% | 2.63% | 0.51% | -0.73% | -1.63% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -61.09% | -239.39% | -472.34% | -327.55% | -231.06% |
| Foreign Exchange rate Adjustments | 345.13% | 78.57% | -299.71% | -30.15% | -829.03% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -253.04% | -181.29% | -155.52% | -98.70% | -74.99% |